CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,232,380 | +32.4% | 418,000 | -2.8% | 4.18% | +30.9% |
| Q2 2023 | $4,708,500 | -38.5% | 430,000 | -51.1% | 3.19% | -43.5% |
| Q1 2023 | $7,660,520 | +20.4% | 878,500 | -13.4% | 5.64% | +44.1% |
| Q4 2022 | $6,364,050 | +477.5% | 1,015,000 | +236.2% | 3.92% | +906.7% |
| Q3 2021 | $1,102,000 | -16.3% | 301,904 | 0.0% | 0.39% | -26.0% |
| Q2 2021 | $1,316,000 | -8.1% | 301,904 | -4.3% | 0.53% | +1.9% |
| Q1 2021 | $1,432,000 | -24.4% | 315,341 | -4.4% | 0.52% | +0.2% |
| Q4 2020 | $1,894,000 | -65.8% | 330,000 | -56.9% | 0.52% | -65.8% |
| Q3 2020 | $5,539,000 | -19.4% | 765,000 | +47.8% | 1.50% | -54.0% |
| Q1 2019 | $6,872,000 | – | 517,500 | – | 3.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |